Similar articles for PMID: 29279429

Year	Number of Results
2002	1
2003	1
2004	2
2005	2
2006	3
2007	9
2008	8
2009	2
2010	3
2011	3
2012	2
2013	5
2014	9
2015	8
2016	7
2017	6
2018	1
2019	2
2020	1
2021	1
2022	4
2024	0

1

[Developing Exercise-mimicking Drugs toward Realization of Preemptive Medicine for Lifestyle-related Diseases.].

Iwabu M, Yamauchi T, Okada-Iwabu M, Kadowaki T. Iwabu M, et al. Clin Calcium. 2018;28(1):73-80. Clin Calcium. 2018. PMID: 29279429 Japanese.

2

Elucidating exercise-induced skeletal muscle signaling pathways and applying relevant findings to preemptive therapy for lifestyle-related diseases.

Iwabu M, Okada-Iwabu M, Kadowaki T, Yamauchi T. Iwabu M, et al. Endocr J. 2022 Jan 28;69(1):1-8. doi: 10.1507/endocrj.EJ21-0294. Epub 2021 Oct 11. Endocr J. 2022. PMID: 34511589 Free article. Review.

3

[Adiponectin receptor-targeted therapy for lifestyle-related diseases].

Iwabu M, Yamauchi T, Okada-Iwabu M, Kadowaki T. Iwabu M, et al. Clin Calcium. 2016 Mar;26(3):413-8. Clin Calcium. 2016. PMID: 26923979 Review. Japanese.

4

[Aging and homeostasis. Development of novel AdipoR-targeted drugs with exercise-mimicking and anti-aging properties.].

Okada-Iwabu M, Yamauchi T, Iwabu M, Kadowaki T. Okada-Iwabu M, et al. Clin Calcium. 2017;27(7):975-981. Clin Calcium. 2017. PMID: 28649104 Japanese.

5

Adiponectin/AdipoR Research and Its Implications for Lifestyle-Related Diseases.

Iwabu M, Okada-Iwabu M, Yamauchi T, Kadowaki T. Iwabu M, et al. Front Cardiovasc Med. 2019 Aug 14;6:116. doi: 10.3389/fcvm.2019.00116. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 31475160 Free PMC article. Review.

6

Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevity.

Okada-Iwabu M, Iwabu M, Yamauchi T, Kadowaki T. Okada-Iwabu M, et al. Diabetol Int. 2019 Sep 19;10(4):237-244. doi: 10.1007/s13340-019-00409-6. eCollection 2019 Oct. Diabetol Int. 2019. PMID: 31592400 Free PMC article. Review.

7

Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity.

Okada-Iwabu M, Iwabu M, Ueki K, Yamauchi T, Kadowaki T. Okada-Iwabu M, et al. Diabetes Metab J. 2015 Oct;39(5):363-72. doi: 10.4093/dmj.2015.39.5.363. Epub 2015 Oct 22. Diabetes Metab J. 2015. PMID: 26566493 Free PMC article. Review.

8

Adiponectin, lipids and atherosclerosis.

Katsiki N, Mantzoros C, Mikhailidis DP. Katsiki N, et al. Curr Opin Lipidol. 2017 Aug;28(4):347-354. doi: 10.1097/MOL.0000000000000431. Curr Opin Lipidol. 2017. PMID: 28463859 Review.

9

Lifestyle plus exercise intervention improves metabolic syndrome markers without change in adiponectin in obese girls.

Park TG, Hong HR, Lee J, Kang HS. Park TG, et al. Ann Nutr Metab. 2007;51(3):197-203. doi: 10.1159/000104137. Epub 2007 Jun 18. Ann Nutr Metab. 2007. PMID: 17587789 Clinical Trial.

10

Lifestyle factors increasing adiponectin synthesis and secretion.

Tishinsky JM, Dyck DJ, Robinson LE. Tishinsky JM, et al. Vitam Horm. 2012;90:1-30. doi: 10.1016/B978-0-12-398313-8.00001-4. Vitam Horm. 2012. PMID: 23017710 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

71 results

Results by year